Effects of Gum Arabic Supplementation in Hemodialysis Patients
NCT03789708 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2019-01-03
Summary
Gum Arabic is a naturally produced gummy exudate from Acacia Senegal tree. It's a complex polysaccharide with proven prebiotic properties. Through its effect on intestinal bacteria, it's expected to reduce systemic levels of toxic bacterial metabolites and reduce inflammatory markers.By increasing fecal bacteria mass it's also expected to reduce blood urea level. These changes are potentially beneficial to hemodialysis patients who suffer from disturbed intestinal flora and a chronic inflammatory status. The investigators hypothesize that supplementing the diet of hemodialysis patients with Gum Arabic for four weeks would reduce inflammatory markers, increase total anti-oxidant capacity and reduce blood urea concentration.
Conditions
- Kidney Failure, Chronic
Interventions
- DIETARY_SUPPLEMENT
-
Gum Arabic
Instantly soluble granules of Gum Arabic; 100% Acacia Senegal
- OTHER
-
Placebo
Maltodextrin powder, easily soluble
Sponsors & Collaborators
-
National Center for Kidney Diseases and Surgery
collaborator UNKNOWN -
Almughtaribeen University
collaborator UNKNOWN -
University of Khartoum
lead OTHER
Principal Investigators
-
Sarra Elamin, MD · Consultant Nephrologist
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-11-01
- Primary Completion
- 2019-03-01
- Completion
- 2019-06-01
Countries
- Sudan
Study Locations
More Related Trials
-
Association Between Phthalates Exposure and Renal Function Impairment in TYpe 2 Diabetes
NCT03622957 ·Status: UNKNOWN
-
Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes
NCT01978405 ·Status: UNKNOWN ·Phase: PHASE4
-
Protective Effects of Oral L-Arginine CI-AKI
NCT02455960 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of The Effect of Rutin and Vitamin C on the Oxidative Stress in Hemodialysis Patients
NCT04955145 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of the Effect of N-acetyl Cysteine on the Renal Graft Function Biomarkers (IL18, NGAL)
NCT01403506 ·Status: UNKNOWN ·Phase: PHASE3
-
Molecular Effects of Vitamin B3 (Niacinamide) in Acute Kidney Injury
NCT02701127 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of N-acetylcysteine on Renal Functioning of Chronic Kidney Diseases(CKD) Patients After General Anesthesia
NCT01251029 ·Status: UNKNOWN ·Phase: PHASE1
-
The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
NCT00247507 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Washing With Clove Extract on Inflammation and Infection Place Logging Shaldon Needle
NCT02865980 ·Status: UNKNOWN ·Phase: NA
-
Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects
NCT00888290 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Curcuminoids and Contrast-induced Acute Kidney Injury
NCT04890704 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effect of Curcumin Against Colistin-induced Nephrotoxicity
NCT05613361 ·Status: RECRUITING ·Phase: PHASE3
-
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
NCT07203287 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography
NCT02070679 ·Status: COMPLETED ·Phase: PHASE3
-
NAC in Preventing CIN in CRF Patients Who Need Enhanced CT Scan in ED
NCT00501475 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
NCT00808795 ·Status: COMPLETED ·Phase: PHASE3
-
Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy
NCT03174821 ·Status: COMPLETED ·Phase: NA
-
Effect of N-Acetylcysteine on Residual Renal Function in Chronic Hemodialysis Patients
NCT00507052 ·Status: UNKNOWN ·Phase: NA
-
Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy
NCT04531163 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Effect of Dexmedetomidine on Kidney Function in EVAR
NCT04766047 ·Status: UNKNOWN ·Phase: NA
-
Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury
NCT01210456 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy
NCT02137863 ·Status: COMPLETED ·Phase: PHASE4
-
N-acetyl Cysteine: the Effectiveness and Safety in a Cohort of Pediatric Patients With Chronic Kidney Disease
NCT04916080 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine
NCT00353340 ·Status: COMPLETED ·Phase: NA
-
The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease
NCT00498342 ·Status: COMPLETED ·Phase: NA